Ignite Creation Date:
2025-12-24 @ 3:53 PM
Ignite Modification Date:
2026-01-27 @ 9:54 PM
Study NCT ID:
NCT04562792
Status:
COMPLETED
Last Update Posted:
2023-06-28
First Post:
2020-08-28
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Low Dose Daunorubicin in Pediatric Relapsed/Refractory Acute Leukemia
Sponsor:
Children's Mercy Hospital Kansas City
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-05-08
Start Date Type:
ACTUAL
Primary Completion Date:
2022-06-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-06-30
Completion Date Type:
ACTUAL
First Submit Date:
2020-08-28
First Submit QC Date:
None
Study First Post Date:
2020-09-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-02-21
Results First Submit QC Date:
None
Results First Post Date:
2023-05-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-06-09
Last Update Post Date:
2023-06-28
Last Update Post Date Type:
ACTUAL